Barclays Maintains an 'Equalweight' on Molina Healthcare (MOH); Highlights From Meeting With Management
Get Alerts MOH Hot Sheet
Price: $200.29 +1.70%
Rating Summary:
11 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
11 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Molina Healthcare (NYSE: MOH) price target of $36.00.
Analyst Raskin's highlighted points after meeting with MOH's management include: 1) Company believes opportunity to more than double revenues from 2011 levels; and 2) Well positioned in CA, FL, & TX, three states expected to have strong growth from health reform’s expansion of Medicaid eligibility in 2014. Raskin leaves FY12/13 EPS estimate unchanged at $1.80/$2.10.
For an analyst ratings summary and ratings history on Molina Healthcare click here. For more ratings news on Molina Healthcare click here.
Shares of Molina Healthcare closed at $32.95 yesterday.
Analyst Raskin's highlighted points after meeting with MOH's management include: 1) Company believes opportunity to more than double revenues from 2011 levels; and 2) Well positioned in CA, FL, & TX, three states expected to have strong growth from health reform’s expansion of Medicaid eligibility in 2014. Raskin leaves FY12/13 EPS estimate unchanged at $1.80/$2.10.
For an analyst ratings summary and ratings history on Molina Healthcare click here. For more ratings news on Molina Healthcare click here.
Shares of Molina Healthcare closed at $32.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Reiterates Outperform Rating on Broadcom Limited (AVGO) Into EPS
- Cummins (CMI) PT Lowered to $675 at Jefferies
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share